MDAIMICRO

Spectral AI, Inc.

HealthcareMedical - Devices
$2.25
$0.00(+1.35%)
52W$1.13
$3.21
Updated May 7, 12:00 AM
RSI71
RS Rating84/99
Beta1.59
Volatility76%
F-Score4/9
Mkt Cap$61M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Spectral AI, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 84), indicating clear outperformance against the broad market. Earnings contraction of 54% provides fundamental context to the price action. However, price is extended 35% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
84
out of 99
Market Leader
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.59
vs S&P 500
HIGH BETA
52W Position
54%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.67
50 SMA > 100 SMA$1.61
100 SMA > 150 SMA$1.73
150 SMA > 200 SMA$1.84

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.98+13.90%ABOVE
50 SMA$1.67+34.86%ABOVE
100 SMA$1.61+39.33%ABOVE
150 SMA$1.73+30.31%ABOVE
200 SMA$1.84+22.08%ABOVE

Price Performance

1D+1.4%
1W+9.8%
1M+37.2%
3M+45.2%
6M+16.0%
YTD+55.2%
1Y+94.0%
3Y-39.8%
52-Week Trading Range54% from low
$2.25
52W Low$1.13
52W High$3.21

Technical Indicators

RSI (14)OVERBOUGHT
70.9
305070
VCP ScoreHOT
7/10
Base depth: 51.0%

Risk Profile

Beta
1.59
52W Vol
76%
ATR
$0.13
Max DD (1Y)
-62%

Volume Analysis

Today
443.8K
50D Avg
619.5K
Vol Ratio
0.72x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24-86%
$-0.41
Q1'25+158%
$0.11
Q2'25-94%
$-0.31
Q3'25-54%
$-0.13
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:+24.74%
TTM:-15.02%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-13.12%

Stock Price CAGR

10 Years:-13.59%
5 Years:-25.42%
3 Years:-39.83%
1 Year:+93.97%

Return on Equity

10Y Avg:-152.4%
5Y Avg:-152.4%
3Y Avg:-214.0%
Last Year:

Key Metrics

Market Cap$61M
Gross Margin44.9%
Net Margin-51.8%
Piotroski F-Score4/9

Frequently Asked Questions

Is MDAI in an uptrend right now?

MDAI has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is MDAI overbought or oversold?

MDAI's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is MDAI outperforming the market?

MDAI has a Relative Strength (RS) Rating of 84 out of 99. Yes, MDAI is a market leader, outperforming 84% of all stocks over the past 12 months.

Where is MDAI in its 52-week range?

MDAI is trading at $2.25, which is 70% of its 52-week high ($3.21) and 54% above its 52-week low ($1.13).

How volatile is MDAI?

MDAI has a Beta of 1.59 and 52-week volatility of 76%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.